XML 73 R7.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies | 3 Months Ended
--- | ---
Sep. 30, 2015
Notes to Financial Statements |
Business Description and Accounting Policies [Text Block] | Note 1. Basis of Presentation and Summary of Significant Accounting Policies: The interim consolidated financial statements of Bio-Techne Corporation (formerly Techne Corporation) and subsidiaries, (the Company) presented here have been prepared by the Company and are unaudited. They have been prepared in accordance with accounting principles generally accepted in the United States of America and with instructions to Form 10-Q and Article 10 of Regulation S-X. They reflect all adjustments which are, in the opinion of management, necessary for a fair presentation of the results for the interim periods presented. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These interim unaudited condensed consolidated financial statements should be read in conjunction with the Company's Consolidated Financial Statements and Notes thereto for the fiscal year ended June 30, 2015, included in the Company's Annual Report on Form 10-K for fiscal 2015. A summary of significant accounting policies followed by the Company is detailed in the Company's Annual Report on Form 10-K for fiscal 2015. The Company follows these policies in preparation of the interim unaudited condensed consolidated financial statements. Available-For-Sale Investments: The Company's available-for-sale securities are carried at fair value using Level 1 and Level 2 inputs. The fair value of the Company's available-for-sale investments at September 30, 2015 and June 30, 2015 were $38.4 million and $56.4 million, respectively. The decrease was caused by the maturity of $3.9 million of available for sale securities with the remainder due to the change in the fair value of the Company's investment in ChemoCentryx, Inc. (CCXI). The amortized cost basis of the Company's available-for-sale investments at September 30, 2015 and June 30, 2015 were $29.5 million and $33.6 million, respectively. Inventories: Inventories consist of (in thousands):
|  | September 30, |  |  | June 30, |
|  | 2015 |  |  | 2015 |
Raw materials |  | $ | 22,874 |  |  | $ | 15,892 |
Finished goods |  |  | 36,093 |  |  |  | 33,685 |
Inventories, net |  | $ | 58,967 |  |  | $ | 49,577 |
At September 30, 2015, the Company had $59.0 million of inventory compared to $50.0 million as of June 30, 2015. The increase is primarily driven by the acquisition of Cliniqa Corporation in July 2015. At both September 30, 2015 and June 30, 2015, the Company had approximately $24 million of excess protein, antibody and chemically-based inventory on hand which was not valued. 4 Property and Equipment: Property and equipment consist of (in thousands):
|  | September 30, |  |  | June 30, |
|  | 2015 |  |  | 2015 |
Land |  | $ | 7,568 |  |  | $ | 7,370 |
Buildings and improvements |  |  | 161,183 |  |  |  | 156,965 |
Machinery and equipment |  |  | 76,281 |  |  |  | 74,385 |
Property and equipment, cost |  |  | 245,032 |  |  |  | 238,720 |
Accumulated depreciation and amortization |  |  | (112,180 | ) |  |  | (108,971 | )
Property and equipment, net |  | $ | 132,852 |  |  | $ | 129,749 |
Intangible Assets: Intangible assets consist of (in thousands):
|  | September 30 |  |  | June 30, |
|  | 2015 |  |  | 2015 |
Developed technology |  | $ | 125,261 |  |  | $ | 108,887 |
Trade names |  |  | 64,009 |  |  |  | 63,867 |
Customer relationships |  |  | 190,340 |  |  |  | 167,494 |
Non-compete agreements |  |  | 3,279 |  |  |  | 3,298 |
Intangible assets |  |  | 382,890 |  |  |  | 343,546 |
Accumulated amortization |  |  | (57,494 | ) |  |  | (50,707 | )
Intangible assets, net |  | $ | 325,396 |  |  | $ | 292,839 |
Changes to the carrying amount of net intangible assets for the quarter ended September 30, 2015 consist of (in thousands):
Beginning balance |  | $ | 292,839 |
Acquisitions |  |  | 46,100 |
Amortization expense |  |  | (7,411 | )
Currency translation |  |  | (6,132 | )
Ending balance |  | $ | 325,396 |
The estimated future amortization expense for intangible assets as of September 30, 2015 is as follows (in thousands):
2016 |  | $ | 21,312 |
2017 |  |  | 27,532 |
2018 |  |  | 27,532 |
2019 |  |  | 26,721 |
2020 |  |  | 26,401 |
2021 |  |  | 26,401 |
Thereaafter |  |  | 169,497 |
|  | $ | 325,396 |
5 Goodwill: Changes to the carrying amount of goodwill for the quarter ended September 30, 2015 consist of (in thousands):
Beginning balance |  | $ | 390,638 |
Acquisitions |  |  | 43,000 |
Currency translation |  |  | (6,321 | )
Ending balance |  | $ | 427,317 |

X
- Definition The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity. + References No definition available. + Details
Name: | us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration